| Drug Name: | Linagliptin (668270-12-0) |
|---|---|
| PubChem ID: | 10096344 |
| SMILES: | CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C |
| InchiKey: | LTXREWYXXSTFRX-QGZVFWFLSA-N |
| Therapeutic Category: | Dipeptidyl-Peptidase IV Inhibitors, Enzyme Inhibitors, Hormones, Hypoglycemic Agents, Incretins, Protease Inhibitors |
| Molecular Weight (dalton) | : | 472.553 |
| LogP | : | 1.14742 |
| Ring Count | : | 4 |
| Hydrogen Bond Acceptor Count | : | 10 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 116.86 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category